Latest Rosiglitazone Stories
The Corporate Whistleblower Center says, "The announcement on July 27th, 2013 that GlaxoSmithKline would pay a $229 million
The first major Actos lawsuit cases moving through the legal system offer hope to patients allegedly harmed by Actos use. LOS ANGELES (PRWEB) August 06, 2013
GranuFlo lawsuit involving patients who allegedly suffered heart attacks, cardiac arrest, stroke or sudden cardiac death while undergoing dialysis treatment with recalled NaturaLyte or GranuFlo
Alert: Diabetes Drug Actos Has Allegedly Been Linked to Serious Health Problems, Including Bladder Cancer DALLAS (PRWEB) June 14, 2013 National plaintiffs’
Alert: Granuflo Allegedly Linked to Serious Health Risks Including Stroke, Heart Attack and Cardiopulmonary Arrest. Dallas, TX (PRWEB) May 08, 2013 The
Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with tAUCB (trans-4-(4-[3-adamantan-1-yl-ureid]-cyclohexyloxy)-benzoic acid) and activating peroxisome proliferator-activator receptorγ (PPARγ) with the thiazolidinedione rosiglitazone on the pathological progression of cardiometabolic syndrome.
The Law Offices of Berman and Berman have just announced that they are taking new Avandia lawsuit and compensation cases.
Three years after restricting sales of Avandia, the US Food and Drug Administration (FDA) has scheduled a health advisory panel to re-evaluate the safety of the diabetes drug.
The law firm of d’Oliveira & Associates has issued a new infographic about the type-2 diabetes drug, Actos, and potential dangers the drug may pose. (PRWEB)
- To fire mitraille at.